Chromatographic profiles of blood plasma free oligosaccharides in patients with cardiovascular disease

  • I. U. Pismenetskaya Dnepropetrovsk Medical Academy SI
  • T. D. Butters Oxford Glycobiology Institute, University of Oxford
Keywords: free oligosaccharides, HPLC-profiles, human plasma, cardiovascular diseases

Abstract

Free oligosaccharides (FOS) are unbound structural analogs of glycans of glycoconjugates. There are several sources of them inside the cell: 1) multistep pathways of N-glycosylation, 2) the cell quality control and endoplastic reticulum-associated degradation of mis-glycosylated and/or misfolded glycoproteins, 3) lysosomal degradation of mature glycoconjugates. Some of these FOS are the earliest indicators of potential glycosylation alterations that would be revealed in the course of the cell quality control and the endoplastic reticulum-associated degradation. Ischemia and hypertension cause stress of intracellular organelles leading to disruption of their functions. The main objective of the work was the characterization of free oligosaccharides (FOS) in plasma obtained from patients with cardiovascular diseases compared to those from healthy subjects to evaluate the potential of these compounds for diagnostics. Chromatographic profiles of FOS composed of 4–12 monosaccharides were obtained and analyzed for quantitative and qualitative differences between the samples. After plasma deproteinization and FOS purification the oligosaccharides were labelled with anthranilic acid (2-AA), separated into the neutral and charged with QAE Sephadex (Q25-120) chromatography and analysed using high-performance liquid chromatography (HPLC). Glucose unit values were determined following comparison with a 2-AA-labelled glucose oligomer ladder derived from a partial hydrolysate of dextran as an external standard. The data were collected and processed using Empower software. The charged FOS were digested with the sialidase from Arthrobacter ureafaciens. 2-AA – labelled free oligosaccharides from transferrin were used as an external standard for the structure decoding. The profiles obtained were compared with intracellular free oligosaccharides of known structures and with the glycan structures and their descriptions in the databases GlycoBase and EUROCarbDB. These approaches allowed predicting a range of glycan structures for each of the main peaks of HPLC profiles of plasma free oligosaccharides and managing ways for their future experimental analysis. In the case of cardiovascular disorders, HPLC profiles of FOS revealed a changing pattern of heterogeneity, depending on the severity of the disease. Three main enlarged glycan species in the netral fraction and one peak in the charged fraction distinguished the FOS of the patients from those of the healthy volunteers. It has been revealed that the neutral marker peaks were represented by polimannose glycans with 5–7 mannose residues and 1–2 residues of N-acetylglucosamine, and one of the major peaks of the charged fraction – by two-antennary complex N-glycan with two sialic acid residues. The study of free oligosaccharides of blood plasma is a new field of glycobiology allowing an evaluation of an organism state at the level of the cell organelle functional status and openning up broad prospects for finding early diagnostic and prognostic markers of cardiac insufficiency. 

References

Alonzi, D.S., Neville, D.C., Lachman, R.H., Dwek, R.A., Butters, T.D., 2008. Glucosylated free oligosaccharides are biomarkers of endoplasmic-reticulum alpha-glucosidase inhibition. Biochem. J. 409(2), 571–580.

Brodsky, J.L., 2012. Cleaning up: ER-associated degradation to the rescue. Cell 151(6), 1163–1167. >> doi: 10.1016/j.cell.2012.11.012

Chakrabarti, A., Chen, A.W., Varner, J.D., 2011. A review of the mammalian unfolded protein response. Biotechnol. Bioeng. 108(12), 2777–2793. >> doi: 10.1002/bit.23282

Harada, Y., Buser, R., Ngwa, E.M., Hirayama, H., Aebi, M., Suzuki, T., 2013a. Eukaryotic oligosaccharyltransferase generates free oligosaccharides during N-glycosylation. J. Biol. Chem. 288(45), 32673–32684. >> doi: 10.1074/jbc.M113.486985

Harada, Y., Nakajima, K., Masahara-Negishi, Y., Freeze, H.H., Angata, T., Taniguchi, N., Suzuki, T., 2013b. Metabolically programmed quality control system for dolichol-linked oligosaccharides. Proc. Natl. Acad. Sci. USA 110(48), 19366–19371. >> doi: 10.1073/pnas.1312187110

Hirayama, H., Seino, J., Kitajima, T., Jigami, Y., Suzuki, T., 2010. Free oligosaccharides to monitor glycoprotein endoplasmic reticulum-associated degradation in Saccharomyces cerevisiae. J. Biol. Chem. 285(16), 12390–12404. >> doi: 10.1074/jbc.M109.082081

Gatica, D., Chiong, M., Lavandero, S., Klionsky, D.J., 2015. Molecular mechanisms of autophagy in the cardiovascular system. Circ. Res. 116(3), 456–467. >> doi: 10.1161/CIRCRESAHA.114.303788

Guo, X.F., Yang, X.J., 2015. Endoplasmic reticulum stress response in spontaneously hypertensive rats is affected by myocardial ischemia reperfusion injury. Exp. Ther. Med. 9(2), 319–326. >> doi: 10.3892/etm.2014.2094

Leitman, J., Ron, E., Ogen-Shtern, N., Lederkremer, G.Z., 2013. Compartmentalization of endoplasmic reticulum quality control and ER-associated degradation factors. DNA Cell Biol. 32(1), 2–7. >> doi: 10.1089/dna.2012.1889

Lemus, L., Goder, V., 2014. Regulation of Endoplasmic Reticulum-Associated Protein Degradation (ERAD) by ubiquitin. Cells 3(3), 824–847. >> doi: 10.3390/cells3030824

Li, M., Tang, Y.Q., Du, R.H., Shi, F.H., Hussein, H.K., Dai, Z., Dai, Y., 2015. CPUY11018, an azimilide derivative, ameliorates isoproterenol-induced cardiac insufficiency through relieving dysfunctional mitochondria and endoplasmic reticulum. J. Pharm. Pharmacol. doi: 10.1111/jphp.12401.

Mei, Y., Thompson, M.D., Cohen, R.A., Tong, X., 2015. Autophagy and oxidative stress in cardiovascular diseases. Biochim. Biophys. Acta 1852(2), 243–251. >> doi: 10.1016/j.bbadis.2014.05.005

Minamino, T., Komuro, I., Kitakaze, M., 2010. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ. Res. 107(9), 1071–1082. >> doi: 10.1161/CIRCRESAHA.110.227819

Minamino, T., Kitakaze, M., 2010. ER stress in cardiovascular disease. J. Mol. Cell Cardiol. 48(6), 1105–1110. >> doi: 10.1016/j.yjmcc.2009.10.026

Nakatsukasa, K., Brodsky, J.L., Kamura, T., 2013. A stalled retrotranslocation complex reveals physical linkage between substrate recognition and proteasomal degradation during ER-associated degradation. Mol. Biol. Cell 24(11), 1765–1775. >> doi: 10.1091/mbc.E12-12-0907

Neville, D.C., Coquard, V., Priestman, D.A., te Vruchte, D.J., Sillence, D.J., Dwek, R.A., Platt, F.M., Butters, T.D., 2004. Analysis of fluorescently labelled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labelling. Anal. Biochem. 331, 275–282.

Neville, D.C., Dwek, R.A., Butters, T.D., 2009. Development of a single column method for the separation of lipid- and protein-derived oligosaccharides. J. Proteome Res. 8, 681–687. >> doi: 10.1021/pr800704t

Orogo, A.M., Gustafsson, A.B., 2015. Therapeutic targeting of autophagy: Potential and concerns in treating cardiovascular disease. Circ. Res. 116(3), 489–503. >> doi: 10.1161/CIRCRESAHA.116.303791

Peric, D., Durrant-Arico, C., Delenda, C., Dupré, T., De Lonlay, P., de Baulny, H.O., Pelatan, C., Bader-Meunier, B., Danos, O., Chantret, I., Moore, S.E., 2010. The compartmentalisation of phosphorylated free oligosaccharides in cells from a CDG Ig patient reveals a novel ER-to-cytosol translocation process. PLoS One 5, e11675. >> doi: 10.1371/journal.pone.0011675

Pismenetska, I.U., 2012. Vplyv immobilizatsii ta deproteinizatsii plasmy krovi na spectr vilnykh oligosakharydiv [Influence of blood plasma immobilization and deproteinization on the spectrum of free oligosaccharides]. Bulletin of Taras Shevchenko National University of Kyiv, Series Biology 60, 27–29 (in Ukrainian).

Pismenetska, I.U., Butters, T.D., 2012. Vil'ni olihosakharydy plazmy krovi praktychno zdorovykh donoriv [Blood plasma free oligosaccharides of practically healthy volunteers]. Scientific Notes of Taurida V.I. Vernadsky National University, Series: Biology, Chemistry 25(1), 182–187 (in Ukrainian).

Ruggiano, A., Foresti, O., Carvalho, P., 2014. Quality control: ER-associated degradation: Protein quality control and beyond. J. Cell Biol. 204(6), 869–879.

Sano, R., Reed, J.C., 2013. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 1833(12), 3460–3470. >> doi: 10.1016/j.bbamcr.2013.06.028

Sun, Y., Zhang, T., Li, L., Wang, J., 2015. Induction of apoptosis by hypertension via endoplasmic reticulum stress. Kidney Blood Press Res. 40(1), 41–51. >> doi: 10.1159/000368481

Suzuki, T., Harada, Y., 2014. Non-lysosomal degradation pathway for N-linked glycans and dolichol-linked oligosaccharides. Biochem. Biophys. Res. Commun. 453(2), 213–219. >> doi: 10.1016/j.bbrc.2014.05.075

Winchester, B., 2005. Lysosomal metabolism of glycoproteins. Glycobiology 15(6), 1R−15R. >> doi: 10.1093/glycob/cwi041

Published
2015-03-26
How to Cite
Pismenetskaya, I. U., & Butters, T. D. (2015). Chromatographic profiles of blood plasma free oligosaccharides in patients with cardiovascular disease. Regulatory Mechanisms in Biosystems, 6(1), 51-56. https://doi.org/10.15421/021510